Structured Assessment of Value Strategy is Key to Effective IDN Partnerships

Posted by Matt Ruple on Thu, Sep 19, 2019

Joe Stevens co-wrote this blog post with Matt Ruple. 

Our life sciences clients often ask, “How can we create mutual value for large, organized customers and ourselves?” While this sounds like a simple question, it masks a number of challenges. In previous posts we discussed how IDNs try to create mutual value, but ultimately elevate one key management goal as their top organizational priority. Frequently, these management goals transform from ideas to action at the service line level, where various departments within an IDN then express therapeutic area level needs. For example, a large IDN taking capitated payments for some of its population may track total cost of care across specialty drugs in oncology and rheumatology, while in cardiology, the focus may be on transition of care and discharge protocols to reduce readmissions.


>
Read More

How Gamification Can Help Pharma Companies Play to Win

Posted by Rachael Pius on Fri, Mar 29, 2019

Maurice Solomon, Victoria Summers and Melissa Visintin co-wrote this article with Rachael Pius.

Whether we like to admit it or not, many of us know the unique rush that comes from swiping a series of multicolored jelly beans in Candy Crush. We’ve experienced the thrill of landing a triple word score in Words With Friends, and we’ve known the satisfaction that comes from—of all things—successfully harvesting a field of wheat in Farmville. Gaming is a universal pursuit, triggering not only our competitive instincts but also our desires for achievement and recognition. And with the rise of app- and social-media-based games, there are more people playing than ever before: The number of online gamers is expected to reach 2.7 billion by 2021, according to gaming analytics firm NewZoo.


>
Read More

Walking the Walk: How Pharma Companies Can Deliver Patient-Centric Experiences

Posted by Hensley Evans on Thu, Jul 12, 2018

The pharmaceutical industry has been talking about patient centricity for a long time, but despite having been a topic of great interest for more than a decade, there remains a lot of uncertainty about what being a truly patient-centric organization means. What does it mean to walk the walk and, more importantly, how can organizations ensure that a focus on patient centricity not only benefits patients but also drives business success?


>
Read More

How Understanding Unconscious Biases Can Improve Pharma Marketing

Posted by Fiona Taylor on Thu, Mar 01, 2018

Every day, our brains outsource hundreds of decisions to our subconscious, which uses mental shortcuts to get us to an answer fast. Understanding these shortcuts and the biases that we may fall prey to can shed light on all sorts of decisions we make, from the car we drive to where we live to how we choose our healthcare treatments.


>
Read More

Social Media Explained by Patients (not Doughnuts or Cats)

Posted by Jackie Cuyvers on Tue, Oct 14, 2014

Patients are social—seeking and sharing health information across social-media channels at an increasing rate. Currently 80% of American Internet users go online for health information, and one out of every three American consumers online posts about his or her health-care experiences using social-media tools and platforms. 1  

>
Read More